CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,256,232
- in 7 filings, $193K under 10b5-1 plans
Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Kroeger Christopher A. −$595K Chief Executive Officer sold 6% of stake
- Hanson Kristopher −$266K General Counsel sold 17% of stake
- Foff Erin Pennock −$124K Chief Medical Officer sold 5% of stake
- Kreitzer Anatol −$96K Chief Discovery Officer sold 7% of stake
- Lillie James Woodruff −$93K Chief Scientific Officer sold 5% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Kreitzer Anatol Chief Discovery Officer | Sale | −12,248 | $7.84 | $96K | 168,678 |
| 2026-10-15 | Foff Erin Pennock Chief Medical Officer | Sale | −15,355 | $8.08 | $124K | 296,906 |
| 2026-10-15 | Hanson Kristopher General Counsel | Sale | −9,020 | $8.08 | $73K | 128,024 |
| 2026-10-15 | Lillie James Woodruff Chief Scientific Officer | Sale | −11,513 | $8.08 | $93K | 198,597 |
| 2026-10-15 | GILLIS JONATHAN CAO and Interim CFO | Sale | −10,167 | $8.08 | $82K | 142,315 |
| 2026-10-15 | Kroeger Christopher A. Chief Executive Officer | Sale | −73,691 | $8.08 | $595K | 1,195,909 |
| 2026-09-16 | Hanson Kristopher General Counsel | Sale 10b5-1 | −16,509 | $11.67 | $193K | 137,044 |
| 2026-08-17 | Kreitzer Anatol Chief Discovery Officer | Grant or award | +6,020 | 180,926 | ||
| 2026-08-17 | Kreitzer Anatol Chief Discovery Officer | Grant or award · Employee Stock Option (right to buy) | +24,455 | 24,455 | ||
| 2026-08-17 | Foff Erin Pennock Chief Medical Officer | Grant or award | +13,360 | 312,261 | ||
| 2026-08-17 | Foff Erin Pennock Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +54,240 | 54,240 | ||
| 2026-08-17 | Hanson Kristopher General Counsel | Grant or award | +7,730 | 153,553 | ||
| 2026-08-17 | Hanson Kristopher General Counsel | Grant or award · Employee Stock Option (right to buy) | +31,395 | 31,395 | ||
| 2026-08-17 | Lillie James Woodruff Chief Scientific Officer | Grant or award | +7,730 | 210,110 | ||
| 2026-08-17 | Lillie James Woodruff Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +31,395 | 31,395 | ||
| 2026-08-17 | GILLIS JONATHAN CAO and Interim CFO | Grant or award | +6,020 | 150,260 | ||
| 2026-08-17 | GILLIS JONATHAN CAO and Interim CFO | Grant or award | +2,222 | 152,482 | ||
| 2026-08-17 | GILLIS JONATHAN CAO and Interim CFO | Grant or award · Employee Stock Option (right to buy) | +24,455 | 24,455 | ||
| 2026-08-17 | GILLIS JONATHAN CAO and Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +2,813 | 2,813 | ||
| 2026-08-17 | Kroeger Christopher A. Chief Executive Officer | Grant or award | +23,145 | 1,269,600 |
Page 1 of 12 · 239 trades